1995
DOI: 10.1248/yakushi1947.115.9_716
|View full text |Cite
|
Sign up to set email alerts
|

Studies on Structure of Light Degradation Products of (-)-(S)-10-(1-Aminocyclopropyl)-9-fluoro-3-methyl-7-oxo-2, 3-dihydro-7H-pyrido [1, 2, 3-de] [1, 4] benzoxazine-6-carboxylic Acid (T-3761) in Aqueous Solution and Solid State

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

1998
1998
2014
2014

Publication Types

Select...
3
2

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(2 citation statements)
references
References 0 publications
0
2
0
Order By: Relevance
“…46 Oxidative decarboxylation (to yield 3-hydroxyquinolone 23, Scheme 12) is one of the processes in the case of T-3761 (Chart 2, Scheme 12), which in contrast to most FQs bears a (1-aminomethyl) rather than a N,NA-dialkylamino group in position 7, but, like RFX has an electron donating substituent in position 8. 47…”
Section: Decarboxylationmentioning
confidence: 99%
“…46 Oxidative decarboxylation (to yield 3-hydroxyquinolone 23, Scheme 12) is one of the processes in the case of T-3761 (Chart 2, Scheme 12), which in contrast to most FQs bears a (1-aminomethyl) rather than a N,NA-dialkylamino group in position 7, but, like RFX has an electron donating substituent in position 8. 47…”
Section: Decarboxylationmentioning
confidence: 99%
“…After more than a decade's clinical application, there have been many adverse drug reactions of pazufloxacin. It is now well documented that the slight adverse drug reactions in gastrointestinal tract are related to the basic structure of fluoroquinolone, especially the R 3 analoges (Scheme-II) 21 .…”
Section: Introductionmentioning
confidence: 99%